Clearmind Medicine Inc
CMND0.774USD
-0.037-4.51%
Close 11/04, 16:00（ET）Quotes delayed by 15 min
4.16MMarket Cap
LossP/E TTM
More Details of Clearmind Medicine Inc Company
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Clearmind Medicine Inc Info
Ticker SymbolCMND
Company nameClearmind Medicine Inc
IPO dateAug 10, 2021
CEODr. Adi Zuloff-Shani
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 10
Address101-1220 West 6Th Avenue
CityVANCOUVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryCanada
Postal codeV6H 1A5
Phone16042601566
Websitehttps://www.clearmindmedicine.com/
Ticker SymbolCMND
IPO dateAug 10, 2021
CEODr. Adi Zuloff-Shani
Company Executives of Clearmind Medicine Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
12.50K
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
39.83K
-27.76%
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
24.75K
+161.59%
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
12.50K
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Oct 31
Updated: Fri, Oct 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Gotham Asset Management, LLC
6.40%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
Other
87.56%
Shareholders
Shareholders
Proportion
Gotham Asset Management, LLC
6.40%
AdvisorShares Investments, LLC
3.83%
Shani (Adi Zuloff)
1.01%
Weiss (Amitay)
0.74%
Rootenberg (Alan)
0.46%
Other
87.56%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
6.40%
Investment Advisor
3.89%
Individual Investor
2.67%
Venture Capital
0.21%
Research Firm
0.07%
Other
86.75%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
20
569.42K
10.58%
-450.78K
2025Q2
27
768.21K
14.28%
-538.45K
2025Q1
28
780.42K
14.56%
-476.27K
2024Q4
29
785.22K
17.91%
-399.68K
2024Q3
27
937.11K
23.14%
+595.17K
2024Q2
25
525.49K
14.81%
+343.69K
2024Q1
26
524.19K
16.46%
+392.16K
2023Q4
23
150.91K
8.83%
+103.68K
2023Q3
22
47.49K
21.65%
+21.51K
2023Q2
20
27.10K
18.95%
+488.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Gotham Asset Management, LLC
344.52K
6.4%
+1.09K
+0.32%
Jun 30, 2025
AdvisorShares Investments, LLC
205.93K
3.83%
-15.00K
-6.79%
Jun 30, 2025
Shani (Adi Zuloff)
54.23K
1.01%
+52.57K
+3153.45%
Oct 31, 2024
Weiss (Amitay)
39.83K
0.74%
-15.31K
-27.76%
Dec 01, 2024
Rootenberg (Alan)
24.75K
0.46%
+15.29K
+161.59%
May 13, 2025
Shachar (Yehonatan Samuel)
12.50K
0.23%
--
--
Dec 01, 2024
Itzhaik (Asaf)
12.50K
0.23%
--
--
Dec 01, 2024
XTX Markets LLC
11.52K
0.21%
+11.52K
--
Jun 30, 2025
J.P. Morgan Securities LLC
3.54K
0.07%
+3.54K
--
Jun 30, 2025
Morgan Stanley Smith Barney LLC
2.56K
0.05%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
AdvisorShares Psychedelics ETF
1.67%
Fidelity Nasdaq Composite Index ETF
0%
AdvisorShares Psychedelics ETF
Proportion1.67%
Fidelity Nasdaq Composite Index ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Date
Type
Ratio
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
Nov 21, 2023
Merger
30→1
